CORRIE MCMAHON: Open Payments
NPI 1104423094 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,733 in 78 payments from 25 companies in 2025. Trend: 2023 $841 · 2024 $1,529 · 2025 $1,733
Food & beverage: $1,733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $398 |
| Otsuka America Pharmaceutical, Inc. | 4 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 6 | $111 |
| PFIZER INC. | 5 | $108 |
| Novo Nordisk Inc | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Lundbeck LLC | 3 | $72 |
| Cranial Technologies, Inc | 4 | $48 |
Products named: VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, AIRSUPRA, NURTEC ODT, JARDIANCE, Wegovy.
Industry payments across IL — which companies pay providers there.
